Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Boucher

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Retrovirology|January 16, 2013
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemicsAna B Abecasis, Annemarie M J Wensing, Dimitris Paraskevis, et al.
Nature Communications|January 12, 2021
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Jeroen J A van Kampen, David A M C van de Vijver, Pieter L A Fraaij, et al.
Retrovirology|April 5, 2013
Limited cross-border infections in patients newly diagnosed with HIV in EuropeDineke Frentz, Annemarie M J Wensing, Jan Albert, et al.
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
BMC Infectious Diseases|July 23, 2014
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in EuropeDineke Frentz, David A M C Van de Vijver, Ana B Abecasis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypesDavid A van de Vijver, Annemarie M J Wensing, Gioacchino Angarano, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 6, 2016
The global spread of HIV-1 subtype B epidemicGkikas Magiorkinis, Konstantinos Angelis, Ioannis Mamais, et al.
Plos Medicine|April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Plos Medicine|June 2, 2015
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-AnalysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Retrovirology|January 16, 2013
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemicsAna B Abecasis, Annemarie M J Wensing, Dimitris Paraskevis, et al.
Nature Communications|January 12, 2021
Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)Jeroen J A van Kampen, David A M C van de Vijver, Pieter L A Fraaij, et al.
Retrovirology|April 5, 2013
Limited cross-border infections in patients newly diagnosed with HIV in EuropeDineke Frentz, Annemarie M J Wensing, Jan Albert, et al.
BMC Infectious Diseases|June 3, 2018
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in EuropeLuna Colagrossi, Lucas E Hermans, Romina Salpini, et al.
BMC Infectious Diseases|July 23, 2014
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in EuropeDineke Frentz, David A M C Van de Vijver, Ana B Abecasis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2006
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypesDavid A van de Vijver, Annemarie M J Wensing, Gioacchino Angarano, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 6, 2016
The global spread of HIV-1 subtype B epidemicGkikas Magiorkinis, Konstantinos Angelis, Ioannis Mamais, et al.
Plos Medicine|April 8, 2015
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Plos Medicine|June 2, 2015
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-AnalysisSoo-Yon Rhee, Jose Luis Blanco, Michael R Jordan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 2, 2015
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in EuropeL Marije Hofstra, Nicolas Sauvageot, Jan Albert, et al.
Pageof 18